124 related articles for article (PubMed ID: 28059830)
1. 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation.
Park GB; Chung YH; Kim D
Anticancer Drugs; 2017 Apr; 28(4):410-420. PubMed ID: 28059830
[TBL] [Abstract][Full Text] [Related]
2. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
Park GB; Kim D
Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells.
Park GB; Kim D; Kim YS; Kim JW; Sun H; Roh KH; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5162-73. PubMed ID: 26244291
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
Park GB; Kim D
Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
[TBL] [Abstract][Full Text] [Related]
5. Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells.
Miyazaki T; Ikeda K; Horie-Inoue K; Inoue S
Biochem Biophys Res Commun; 2014 Sep; 452(3):828-33. PubMed ID: 25218471
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin mitigates streptozotocin-induced type 1 diabetes in mice through downregulation of ADAM10 and ADAM17.
Abdel-Bakky MS; Alqasoumi A; Altowayan WM; Amin E; Darwish MA
Life Sci; 2022 Jan; 289():120224. PubMed ID: 34896343
[TBL] [Abstract][Full Text] [Related]
7. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.
Chung YH; Kim D
Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597
[TBL] [Abstract][Full Text] [Related]
8. Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells.
El Khoury F; Corcos L; Durand S; Simon B; Le Jossic-Corcos C
Int J Oncol; 2016 Dec; 49(6):2558-2568. PubMed ID: 27748801
[TBL] [Abstract][Full Text] [Related]
9. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
10. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
11. PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.
Cheng C; Xie Z; Li Y; Wang J; Qin C; Zhang Y
Biomed Pharmacother; 2018 Dec; 108():194-200. PubMed ID: 30219676
[TBL] [Abstract][Full Text] [Related]
12. Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.
Gavert N; Sheffer M; Raveh S; Spaderna S; Shtutman M; Brabletz T; Barany F; Paty P; Notterman D; Domany E; Ben-Ze'ev A
Cancer Res; 2007 Aug; 67(16):7703-12. PubMed ID: 17699774
[TBL] [Abstract][Full Text] [Related]
13. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
14. TrkB/C-induced HOXC6 activation enhances the ADAM8-mediated metastasis of chemoresistant colon cancer cells.
Park GB; Choi S; Yoon YS; Kim D
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846772
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition.
Dinicola S; Pasqualato A; Proietti S; Masiello MG; Palombo A; Coluccia P; Canipari R; Catizone A; Ricci G; Harrath AH; Alwasel SH; Cucina A; Bizzarri M
Life Sci; 2016 Jan; 145():174-83. PubMed ID: 26746659
[TBL] [Abstract][Full Text] [Related]
16. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity.
Druzhkova I; Ignatova N; Prodanets N; Kiselev N; Zhukov I; Shirmanova M; Zagainov V; Zagaynova E
Clin Colorectal Cancer; 2019 Mar; 18(1):e74-e86. PubMed ID: 30415989
[TBL] [Abstract][Full Text] [Related]
17. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
[TBL] [Abstract][Full Text] [Related]
18. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
19. Etoposide induces apoptosis and upregulation of TACE/ADAM17 and ADAM10 in an in vitro male germ cell line model.
Lizama C; Ludwig A; Moreno RD
Biochim Biophys Acta; 2011 Jan; 1813(1):120-8. PubMed ID: 20800622
[TBL] [Abstract][Full Text] [Related]
20. A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo.
Li DD; Zhao CH; Ding HW; Wu Q; Ren TS; Wang J; Chen CQ; Zhao QC
Cell Prolif; 2018 Oct; 51(5):e12480. PubMed ID: 30069943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
